Eli Lilly Canada Inc. / Kenneth L Custer, President and General Manager - Registration - Organization - Lobbyists Registry - Office of the Registrar or Lobbying of BC

Registration versions:

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 261865
Submitted by lobbyist on: November 1, 2012 04:30:29 PM
Accepted by Registrar on: November 15, 2012 08:08:47 AM

Designated Filer Information

Name: Stovall, Hal

Contact Information: 5120 Wilson Drive
Delta, BC, V4M 1P4	604-764-2914
Canada

Organization Information

Name: Eli Lilly Canada Inc

Business Activities:

research, develop and provide medication for patients

Contact Information: 5120 Wilson Drive
Delta, BC, V4M 1P4	604-764-2914
Canada

Relevant Affiliates

Type: Subsidiary Corporation

Parent Contact Information

Business Name	Mailing Address	Contact Information
Eli Lilly and Company	Lilly Corporate Center Indianapolis, IN 46285 United States of America	Phone: 604-948-1297
Eli Lilly Canada Inc	5120 Wilson Drive Delta, BC V4M 1P4 Canada	Phone: 604-948-1297

Government or Government Agency Funding

The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

Registration start date: November 1, 2012
Registration end date: June 3, 2013

Organization's In-House Lobbyists

Name:

Stovall, Hal

Start Date: November 1, 2012

Inactivation Date:

June 10, 2013

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Provide input into the decision making process of the Ministry of Health and Pharmacare as it relates to the business of Eli Lilly and the pharmaceutical sector

Target Contacts

Target Type	Name	Title or Constituency	Date Added
Minister	MacDiarmid, Margaret	Minister of Health	November 5, 2012
Public Agency	Health		November 5, 2012

Health

Development, establishment, amendment or termination of any program, policy or decision

Development, establishment, amendment or termination of a product listing agreement and/or a drug policy

Target Contacts

Target Type	Name	Title or Constituency	Date Added
MLA	MacDiarmid, Margaret	Vancouver-Fairview	November 14, 2012
Public Agency	Health		November 1, 2012